Article
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
FEBS letters - 15 May 2007
Hiraga Nobuhiko, Imamura Michio, Tsuge Masataka, Noguchi Chiemi, Takahashi Shoichi, Iwao Eiji, Fujimoto Yoshifumi, Abe Hiromi, Maekawa Toshiro, Ochi Hidenori, Tateno Chise, Yoshizato Katsutoshi, Sakai Akihito, Sakai Yoshio, Honda Masao, Kaneko Shuichi, Wakita Takaji, Chayama Kazuaki
Abstract excerpt
We developed a reverse genetics system of hepatitis C virus (HCV) genotypes 1a and 2a using infectious clones and human hepatocyte chimeric mice. We inoculated cell culture-produced genotype 2a (JFH-1) HCV intravenously. We also injected genotype 1a CV-H77C clone RNA intrahepatically. Mice inoculated with HCV by both procedures developed measurable and transmissible viremia. Interferon (IFN) alpha treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
